YEM Search

搜索结果

SLC12A5

靶点ID:TCMBANKGE008386

靶点别名:EIEE34; EIG14; KCC2; hKCC2

靶点描述:solute carrier family 12 member 5

染色体:20

染色体位置:20q13.12

靶点类型:protein-coding

HERB_ID:-

HGNC_Link:13818

OMIM_Link:606726

Ensembl_Link:ENSG00000124140

靶点对应的植物

ID	拉丁名	药名	药用植物名	功能与主治	来源	药用部位	使用民族

靶点对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN001521	Potassium chloride		KCl	74.55 g/mol	[Cl-].[K+]
TCMBANKIN012299	potassium		K	39.098 g/mol	[K]
TCMBANKIN057903	Potassium chloride		KCl	74.55 g/mol	[Cl-].[K+]
TCMBANKIN057905	ferrum	iron	Fe	55.84 g/mol	[Fe]
TCMBANKIN057965	arginine	L(+ )-arginine;EINECS 230-571-3; (2S)-2-amino-5-guanidino-pentanoic acid; EINECS 200-811-1; (S)-2-Amino-5-guanidinovaleric acid; DL-Arginine; (L)-Arginine; Arginine hydrochloride(USAN); 1-Amino-4-guanidovaleric acid; L-Ornithine, N5-(aminoiminomethyl)-; W381918_ALDRICH; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; Arginine [USAN:INN]; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; L-Arginine, labeled with tritium; AI3-24165; AIDS-121865; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; NSC203450 (HYDROCHLORIDE); A5006_SIAL; (+-)-Arginine; L-Norvaline, 5-((aminoiminomethyl)amino)-; AIDS121865; Lopac0_000077; Tocris-0663; Arginine (VAN); 4455-52-1; CCRIS 3609; BRN 1725413; NCGC00015064-01; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; (2S)-2-amino-5-guanidinopentanoic acid; D02982; Argininum [INN-Latin]; C00062; 7200-25-1; A8094_SIGMA; 11009_FLUKA; Poly(L-arginine); (2S)-2-amino-5-guanidino-valeric acid; Lopac-A-5006; NSC 206269; HSDB 1429; CHEBI:16467; L-Arginine, homopolymer; L-Arginine (9CI); Arginina [INN-Spanish]; 4-04-00-02648 (Beilstein Handbook Reference); (S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; Arginine, L- (8CI); L-Arginine (JP15); EU-0100077; L-alpha-Amino-delta-guanidinovaleric acid; NSC7914 (HYDROCHLORIDE); Arginine (USP); 1119-34-2 (HYDROCHLORIDE); Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; L-Arg; L-Norvaline, 5-[(aminoiminomethyl)amino]-; 142-49-4; A4474_SIAL; InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s; L-Arginin; Arginine, DL-; NCGC00024715-01;AC1ODX8E; [(4S)-5-amino-4-azaniumyl-5-oxopentyl]-(diaminomethylidene)azanium; [AMINO({[(4S)-4-AMMONIO-4-CARBAMOYLBUTYL]AMINO})METHYLIDENE]AZANIUM	C6H14N4O2	174.2 g/mol	C(CC(C(=O)O)N)CN=C(N)N
TCMBANKIN060111	17alpha-estradiol		C18H24O2	272.4 g/mol	CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O
TCMBANKIN061102	LFA		C20H42	282.55 g/mol	CCCCCCCCCCCCCCCCCCCC

靶点对应的疾病

疾病ID	疾病名	MeSH名	HPO名	UMLS名	疾病类型

TCMBANKDI000002	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Sign or Symptom	phenotype
TCMBANKDI000004	Pathological Conditions, Signs and Symptoms	Constitutional symptom	Sign or Symptom	phenotype
TCMBANKDI000166	-	-	Neoplastic Process	disease
TCMBANKDI002065	Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI002087	-	-	Disease or Syndrome	disease
TCMBANKDI002262	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI003353	Pathological Conditions, Signs and Symptoms; Neoplasms	-	Neoplastic Process	phenotype
TCMBANKDI004331	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI005272	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Sign or Symptom	phenotype
TCMBANKDI005794	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI007012	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Pathologic Function	phenotype
TCMBANKDI007770	Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases	Abnormality of the respiratory system	Sign or Symptom	phenotype
TCMBANKDI009278	Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI011883	-	-	Mental Process	phenotype
TCMBANKDI012157	Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	group
TCMBANKDI014132	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI014716	Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI015485	Mental Disorders	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI016336	Neoplasms	-	Neoplastic Process	disease
TCMBANKDI017008	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI018017	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Sign or Symptom	phenotype
TCMBANKDI023156	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI023464	Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI024057	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Disease or Syndrome	phenotype
TCMBANKDI024596	Nervous System Diseases	-	Disease or Syndrome	disease
TCMBANKDI028945	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	Abnormality of the nervous system	Disease or Syndrome	disease
TCMBANKDI029054	Mental Disorders	-	Mental or Behavioral Dysfunction	group
TCMBANKDI030540	Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases	Abnormality of the genitourinary system; Neoplasm	Neoplastic Process	disease
TCMBANKDI031189	Neoplasms	Neoplasm; Abnormality of the respiratory system	Neoplastic Process	disease
TCMBANKDI031522	Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases	Abnormality of the genitourinary system; Neoplasm	Neoplastic Process	disease
TCMBANKDI031570	-	Abnormality of the nervous system	Mental or Behavioral Dysfunction	disease
TCMBANKDI031754	Pathological Conditions, Signs and Symptoms; Nervous System Diseases	-	Pathologic Function	phenotype